# ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer

> **NCT01675128** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 24 (actual)

## Conditions studied

- Colorectal Neoplasms
- Colorectal Carcinoma
- Colorectal Tumors

## Interventions

- **DRUG:** ISIS 183750
- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT01675128
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2014-12
- **Final completion:** 2015-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01675128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01675128, "ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01675128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*